Also, Yuanyuan et al. showed that the IL-18-607A > C polymorphism decreased the risk of prostate cancer in an Asian population but increased the risk of prostate cancer in a Caucasian population [17]. This evidence concerns the gene IL18 and prostate carcinoma.